Pfizer is buying this Botox-maker in the world’s largest pharma deal ever!
Advertisement
In what is said to be a colossal deal in pharmaceutical sector, US drug giant Pfizer is all set to buy Botox maker Allergan for whooping $150 million.
If everything goes as planned, the deal will give the $45-billion Pfizer the tax benefits of an Irish domicile.
Pfizer has been desperately looking to buy Allergan after its failed attempt to buy Anglo-Swedish drug maker AstraZeneca for $118 billion.
Allergan has morphed from being an ophthalmic-focused drug firm to a serious multiproduct branded industry heavyweight through a series of deals over the past three years.
As per reports, this historic deal will involve Pfizer paying with 11.3 of its shares for each Allergan share.
Pfizer will bring together its drugs such as Lipitor, Viagra and nerve pain treatment Lyrica with Allergan's Namenda memory loss treatment, Restasis dry eye medication and other leading eye-care brands.
A Reuters report quoted many industry analysts and investors, who believed that Pfizer could be bulking up with Allergan's fast-growing brands as a prelude to splitting by 2017 into two companies - one selling high-margin branded drugs and one selling inexpensive generics that have dragged down Pfizer results over the past few years.
Allergan was founded in 1948 By Gavin Herbert and the company first marketed its first nasal drop- Allergan.
(Image: Thinkstock)
Advertisement
If everything goes as planned, the deal will give the $45-billion Pfizer the tax benefits of an Irish domicile.
Pfizer has been desperately looking to buy Allergan after its failed attempt to buy Anglo-Swedish drug maker AstraZeneca for $118 billion.
Allergan has morphed from being an ophthalmic-focused drug firm to a serious multiproduct branded industry heavyweight through a series of deals over the past three years.
As per reports, this historic deal will involve Pfizer paying with 11.3 of its shares for each Allergan share.
Advertisement
A Reuters report quoted many industry analysts and investors, who believed that Pfizer could be bulking up with Allergan's fast-growing brands as a prelude to splitting by 2017 into two companies - one selling high-margin branded drugs and one selling inexpensive generics that have dragged down Pfizer results over the past few years.
Allergan was founded in 1948 By Gavin Herbert and the company first marketed its first nasal drop- Allergan.
(Image: Thinkstock)
Advertisement
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market